270 related articles for article (PubMed ID: 26751771)
1. CFTR is a tumor suppressor gene in murine and human intestinal cancer.
Than BL; Linnekamp JF; Starr TK; Largaespada DA; Rod A; Zhang Y; Bruner V; Abrahante J; Schumann A; Luczak T; Walter J; Niemczyk A; O'Sullivan MG; Medema JP; Fijneman RJ; Meijer GA; Van den Broek E; Hodges CA; Scott PM; Vermeulen L; Cormier RT
Oncogene; 2016 Aug; 35(32):4179-87. PubMed ID: 26751771
[TBL] [Abstract][Full Text] [Related]
2. The role of KCNQ1 in mouse and human gastrointestinal cancers.
Than BL; Goos JA; Sarver AL; O'Sullivan MG; Rod A; Starr TK; Fijneman RJ; Meijer GA; Zhao L; Zhang Y; Largaespada DA; Scott PM; Cormier RT
Oncogene; 2014 Jul; 33(29):3861-8. PubMed ID: 23975432
[TBL] [Abstract][Full Text] [Related]
3. Cystic Fibrosis, CFTR, and Colorectal Cancer.
Scott P; Anderson K; Singhania M; Cormier R
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326161
[TBL] [Abstract][Full Text] [Related]
4. Cftr Modulates Wnt/β-Catenin Signaling and Stem Cell Proliferation in Murine Intestine.
Strubberg AM; Liu J; Walker NM; Stefanski CD; MacLeod RJ; Magness ST; Clarke LL
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):253-271. PubMed ID: 29675451
[TBL] [Abstract][Full Text] [Related]
5. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
7. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
8. Role of ion channels in gastrointestinal cancer.
Anderson KJ; Cormier RT; Scott PM
World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
[TBL] [Abstract][Full Text] [Related]
9. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.
Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J
Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292
[TBL] [Abstract][Full Text] [Related]
11. Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.
Bijvelds MJ; Bot AG; Escher JC; De Jonge HR
Gastroenterology; 2009 Sep; 137(3):976-85. PubMed ID: 19454284
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression.
Steagall WK; Elmer HL; Brady KG; Kelley TJ
Am J Respir Cell Mol Biol; 2000 Jan; 22(1):45-50. PubMed ID: 10615064
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide modulates cystic fibrosis transmembrane conductance regulator chloride channel expression in rat proximal colon and human intestinal epithelial cells.
Novaira HJ; Ornellas DS; Ortiga-Carvalho TM; Zhang XM; Souza-Menezes J; Guggino SE; Guggino WB; Morales MM
J Endocrinol; 2006 Apr; 189(1):155-65. PubMed ID: 16614390
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.
Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM
J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741
[TBL] [Abstract][Full Text] [Related]
17. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
19.
Winter M; Rokavec M; Hermeking H
Cancer Res; 2021 Jul; 81(13):3621-3634. PubMed ID: 34224368
[TBL] [Abstract][Full Text] [Related]
20. Novel role of cystic fibrosis transmembrane conductance regulator in maintaining adult mouse olfactory neuronal homeostasis.
Pfister S; Weber T; Härtig W; Schwerdel C; Elsaesser R; Knuesel I; Fritschy JM
J Comp Neurol; 2015 Feb; 523(3):406-30. PubMed ID: 25271146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
